StockIQpro
NASDAQ:EOLS

Evolus, Inc.

Track all markets on TradingView
Track all markets on TradingView

Evolus, Inc.'s revenue grew 11.6% in fiscal 2025 to $297.2M while operating margin rose to −11.0%, its highest in 7 years. Free cash flow was −$45.7M, −15.4% of revenue, and the diluted share count rose 4.0%.Summary generated from Evolus, Inc.'s SEC filings. Latest annual report filed Mar 3, 2026.

Key statistics

Fiscal 2025 from SEC filings. Methodology
Revenue (FY25)$297.2M
Revenue growth+11.6%
Revenue, 5-yr CAGR+39.4%
Gross margin66.3%
Operating margin−11.0%
Net margin−17.4%
ROIC−47.2%
Return on equityn/a
Debt / equityn/a
Free cash flow−$45.7M
FCF margin−15.4%
Share count change+4.0%

Financials

Fiscal years, $M
Item20212022202320242025
Revenue100149202266297
Operating income−44−65−49−34−33
Net income−47−74−62−50−52
Free cash flow−34−87−34−19−46

Recent filings

From SEC EDGAR

Peers

Pharmaceutical preparations